This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention Center in BostonBoston, MA

Xavier de Mollerat du Jeu
Senior Director, Research and Development at Thermo Fisher Scientific, USA
Speaker

Profile

Xavier de Mollerat du Jeu, Ph.D. is the Senior Director of R&D for Cell and Gene Therapy at Thermo Fisher Scientific. His team is responsible for integrating new closed modular platforms into cell therapy production workflows. In his prior role, Xavier and his team developed cell therapy processing platforms and identified new DNA delivery approaches for hard to transfect cell lines and primary/stem cells—inventing Lipofectamine® 3000 and authoring several patents around nucleic acid delivery in the process. Xavier studied molecular biology and plant physiology at the University of Montpellier II and received his Ph.D. in human genetics from Clemson University.